Retractable Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Retractable Technologies heeft een totaal eigen vermogen van $85.4M en een totale schuld van $1.4M, wat de schuld-eigenvermogensverhouding op 1.6% brengt. De totale activa en totale passiva bedragen respectievelijk $160.7M en $75.3M.

Belangrijke informatie

1.6%

Verhouding schuld/eigen vermogen

US$1.39m

Schuld

Rente dekkingsratio	n/a
Contant	US$41.90m
Aandelen	US$85.44m
Totaal verplichtingen	US$75.31m
Totaal activa	US$160.74m

Recente financiële gezondheidsupdates

Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?

Mar 16

Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?

Dec 14

Recent updates

Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?

Mar 16

Do Insiders Own Lots Of Shares In Retractable Technologies, Inc. (NYSEMKT:RVP)?

Feb 26

Retractable Technologies (NYSEMKT:RVP) Knows How To Allocate Capital Effectively

Feb 08

Here's Why I Think Retractable Technologies (NYSEMKT:RVP) Might Deserve Your Attention Today

Jan 12

Here's Why We Don't Think Retractable Technologies's (NYSEMKT:RVP) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 28

Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?

Dec 14

How Should Investors React To Retractable Technologies' (NYSEMKT:RVP) CEO Pay?

Dec 01

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $70.6M ) RVP } overtreffen de korte termijn passiva ( $7.4M ).

Langlopende schulden: De kortetermijnactiva RVP ( $70.6M ) overtreffen de langetermijnschulden ( $67.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RVP heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van RVP is de afgelopen 5 jaar gedaald van 11% naar 1.6%.

Schuldendekking: De schuld van RVP wordt goed gedekt door de operationele kasstroom ( 357.9% ).

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van RVP op haar schulden goed worden gedekt door EBIT.

Retractable Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?

Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?

Recent updates

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.13 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: US$0.012 (vs US$0.031 in 1Q 2023)

Full year 2023 earnings released: US$0.24 loss per share (vs US$0.15 profit in FY 2022)

Retractable Technologies, Inc., Annual General Meeting, May 10, 2024

Third quarter 2023 earnings released: US$0.13 loss per share (vs US$0.16 profit in 3Q 2022)

Second quarter 2023 earnings released: US$0.13 loss per share (vs US$0.11 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.031 (vs US$0.23 in 1Q 2022)

Full year 2022 earnings released: EPS: US$0.15 (vs US$1.65 in FY 2021)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.16 (vs US$0.19 in 3Q 2021)

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Insufficient new directors

Retractable Technologies, Inc.(NYSEAM:RVP) dropped from Russell 2000 Dynamic Index

Retractable Technologies, Inc. Reports Reduction in Workforce

Insufficient new directors

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Insufficient new directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Retractable Technologies, Inc., Annual General Meeting, May 10, 2022

Third quarter 2021 earnings released: EPS US$0.19 (vs US$0.33 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS US$0.31 (vs US$0.11 in 2Q 2020)

Retractable Technologies, Inc.(NYSEAM:RVP) dropped from Russell 3000E Value Index

Investor sentiment improved over the past week

Retractable Technologies, Inc. (NYSEAM:RVP) announces an Equity Buyback for $10 million worth of its shares.

First quarter 2021 earnings released: EPS US$0.53 (vs US$0.005 in 1Q 2020)

Independent Director recently sold US$50k worth of stock

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS US$0.80 (vs US$0.075 in FY 2019)

Is Retractable Technologies (NYSEMKT:RVP) Using Too Much Debt?

Investor sentiment improved over the past week

Do Insiders Own Lots Of Shares In Retractable Technologies, Inc. (NYSEMKT:RVP)?

Investor sentiment deteriorated over the past week

Vice President of Sales Development notifies of intention to sell stock

Retractable Technologies, Inc. Wins Firm Fixed Price and Cost Reimbursement Contract and Purchase Order

Retractable Technologies (NYSEMKT:RVP) Knows How To Allocate Capital Effectively

Independent Director recently sold US$186k worth of stock

Investor sentiment improved over the past week

New 90-day high: US$15.69

Founder recently sold US$3.0m worth of stock

Investor sentiment improved over the past week

Here's Why I Think Retractable Technologies (NYSEMKT:RVP) Might Deserve Your Attention Today

Here's Why We Don't Think Retractable Technologies's (NYSEMKT:RVP) Statutory Earnings Reflect Its Underlying Earnings Potential

Investor sentiment deteriorated over the past week

New 90-day high: US$15.00

Investor sentiment improved over the past week

Does Retractable Technologies (NYSEMKT:RVP) Have A Healthy Balance Sheet?

Investor sentiment improved over the past week

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market pulls back on stock over the past week

How Should Investors React To Retractable Technologies' (NYSEMKT:RVP) CEO Pay?

Market bids up stock over the past week

New 90-day high: US$10.07

Third quarter 2020 earnings released: EPS US$0.33

Market pulls back on stock over the past week

New 90-day low - US$5.76

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven